Physician profile
Manisha Garg
NPI 1215215389
$8,222.11
in general payments reported to CMS, 2019-2025
40 companies · $1,046 in 2025
The $1,046 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $499 · 2021: $1,237 · 2022: $1,569 · 2023: $2,078 · 2024: $1,452 · 2025: $1,046.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,575 · Education: $0.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,575.30 |
| Education | $0.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,404.83 | 2019-2025 | Mounjaro, Jardiance, Baqsimi |
| Novo Nordisk INC | $1,128.85 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbott Laboratories | $759.99 | 2019-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $502.80 | 2020-2024 | Dexcom G6 Transmitter |
| Mannkind Corporation | $432.67 | 2019-2025 | Afrezza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $410.00 | 2019-2025 | Jardiance, Synjardy |
| Xeris Pharmaceuticals, INC. | $378.86 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Sanofi-Aventis U.S. LLC | $349.58 | 2019-2024 | |
| Tandem Diabetes Care, INC. | $280.85 | 2020-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbvie INC. | $240.16 | 2020-2025 | |
| Medtronic, INC. | $196.59 | 2022-2025 | Minimed 780g |
| Beta Bionics, INC. | $181.90 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Corcept Therapeutics | $179.65 | 2022-2025 | Korlym |
| Astrazeneca Pharmaceuticals LP | $178.56 | 2019-2023 | Farxiga |
| Amneal Pharmaceuticals LLC | $142.89 | 2023-2025 | Unithroid |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manisha Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.